Suppression Versus Induction of Androgen Receptor Functions by the Phosphatidylinositol 3-Kinase/Akt Pathway in Prostate Cancer LNCaP Cells with Different Passage Numbers*

The phosphatidylinositol 3-kinase (PI3K)/Akt pathway controls several important biological functions, such as cell growth regulation, apoptosis, and migration. However, the way in which PI3K/Akt controls androgen receptor (AR)-mediated prostate cancer cell growth remains unclear and controversial. Here, we demonstrate that the PI3K/Akt pathway regulates AR activity in a cell passage number-dependent manner. Specifically, PI3K/Akt pathway can suppress AR activity in androgen-dependent LNCaP cells with low passage numbers. In contrast, it can also enhance AR activity in LNCaP cells with high passage numbers. Furthermore, we also demonstrate that insulin-like growth factor-1 can activate the PI3K/Akt pathway that results in the phosphorylation of AR at Ser210 and Ser790. The consequence of these events may then change the stability of AR protein. Together, our results demonstrate that the PI3K/Akt pathway may have distinct mechanisms to modulate AR functions in various stages of prostate cancer cells and that a combined therapy of antiandrogens and anti-PI3K/Akt inhibitors may be worth considering as a future therapeutic approach to battle prostate cancer.

• Publication year

  2003

• Venue

  Journal of Biological Chemistry

• Publication date

  2003-12-19

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1074/jbc.M300676200PMID 14555644
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Androgen receptor (AR) coregulators: an overview.

  2002cited by this paper
• Androgen Receptor Phosphorylation

  2002cited by this paper
• Phosphorylation‐dependent ubiquitylation and degradation of androgen receptor by Akt require Mdm2 E3 ligase

  2002cited by this paper
• Suppression of Estrogen Receptor-mediated Transcription and Cell Growth by Interaction with TR2 Orphan Receptor*

  2002cited by this paper
• Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor

  2001cited by this paper
• Role of PI3K signaling in survival and progression of LNCaP prostate cancer cells to the androgen refractory state.

  2001cited by this paper
• Antagonism between PTEN/MMAC1/TEP-1 and Androgen Receptor in Growth and Apoptosis of Prostatic Cancer Cells*

  2001cited by this paper
• The RING finger protein SNURF modulates nuclear trafficking of the androgen receptor.

  2000cited by this paper
• Increase of androgen-induced cell death and androgen receptor transactivation by BRCA1 in prostate cancer cells.

  2000cited by this paper
• Mdm2 Is a RING Finger-dependent Ubiquitin Protein Ligase for Itself and p53*

  2000cited by this paper
• Inhibiting proteasomes in human HepG2 and LNCaP cells increases endogenous androgen receptor levels.

  2000cited by this paper
• HER-2/neu promotes androgen-independent survival and growth of prostate cancer cells through the Akt pathway.

  2000cited by this paper
• Increased AKT Activity Contributes to Prostate Cancer Progression by Dramatically Accelerating Prostate Tumor Growth and Diminishing p27Kip1 Expression*

  2000cited by this paper
• The multiple roles of PTEN in tumor suppression.

  2000cited by this paper
• Antiapoptotic signaling in LNCaP prostate cancer cells: a survival signaling pathway independent of phosphatidylinositol 3'-kinase and Akt/protein kinase B.

  1999cited by this paper
• The phosphatidylinositol 3'-kinase pathway is a dominant growth factor-activated cell survival pathway in LNCaP human prostate carcinoma cells.

  1999cited by this paper
• Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53

  1997cited by this paper
• PI3K: downstream AKTion blocks apoptosis.

  1997cited by this paper

• Dynamic Shifts in ER-Plasma Membrane Junctions Signaling Define Pro-Metastatic N-Glycosylation and Predict Prostate Cancer Progression.

  2026cites this paper
• Application of Original Prostate Cancer Progression Model Interacting with Fibroblasts in Preclinical Research

  2024cites this paper
• Passaging of gingival fibroblasts from periodontally healthy and diseased sites upregulates osteogenesis-related genes

  2023cites this paper
• Chromosomal instability and its effect on cell lines

  2023cites this paper
• International Union of Basic and Clinical Pharmacology CXIII: Nuclear Receptor Superfamily—Update 2023

  2023cites this paper
• Pharmacological inhibition of the SKP2/p300 signaling axis restricts castration-resistant prostate cancer

  2023cites this paper
• ComProliM: A cell growth assay robust to initial cell number in co-culture system

  2023cites this paper
• A protocol to establish cell line models from rare pediatric solid tumors

  2023cites this paper
• A hotspot for posttranslational modifications on the androgen receptor dimer interface drives pathology and anti-androgen resistance

  2023cites this paper
• Advances with androgen deprivation therapy for prostate cancer

  2022cites this paper
• Serial Passaging of RAW 264.7 Cells Modulates Intracellular AGE Formation and Downregulates RANKL-Induced In Vitro Osteoclastogenesis

  2022cites this paper
• Acetyl-CoA Counteracts the Inhibitory Effect of Antiandrogens on Androgen Receptor Signaling in Prostate Cancer Cells

  2022cites this paper
• Decrypting a path based approach for identifying the interplay between PI3K and GSK3 signaling cascade from the perspective of cancer

  2022cites this paper
• Targeting androgen receptor (AR) with antiandrogen Enzalutamide increases prostate cancer cell invasion yet decreases bladder cancer cell invasion via differentially altering the AR/circRNA-ARC1/miR-125b-2-3p or miR-4736/PPARγ/MMP-9 signals

  2021cites this paper
• Her2 Expression in Circulating Tumor Cells Is Associated with Poor Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer

  2021cites this paper
• Androgen Receptor Activation in Glioblastoma Can Be Achieved by Ligand-Independent Signaling through EGFR—A Potential Therapeutic Target

  2021cites this paper
• Steroid Receptors in Breast Cancer: Understanding of Molecular Function as a Basis for Effective Therapy Development

  2021cites this paper
• Novel therapeutic strategies for Alzheimer's disease: Implications from cell-based therapy and Nanotherapy.

  2020cites this paper
• Resveratrol inhibits proliferation and promotes apoptosis via the androgen receptor splicing variant 7 and PI3K/AKT signaling pathway in LNCaP prostate cancer cells

  2020cites this paper
• GRB10 sustains AR activity by interacting with PP2A in prostate cancer cells

  2020cites this paper
• Loss of Fibroblast-Dependent Androgen Receptor Activation in Prostate Cancer Cells is Involved in the Mechanism of Acquired Resistance to Castration

  2019cites this paper
• Protein corona variation in nanoparticles revisited: A dynamic grouping strategy.

  2019cites this paper
• The Role of Exploratory Data Analysis and Pre-processing in Omics Studies

  2019cites this paper
• Androgen receptor suppresses prostate cancer metastasis but promotes bladder cancer metastasis via differentially altering miRNA525-5p/SLPI-mediated vasculogenic mimicry formation.

  2019cites this paper
• ErbB-2 signaling in advanced prostate cancer progression and potential therapy

  2019cites this paper
• Pirfenidone, an Anti-Fibrotic Drug, Suppresses the Growth of Human Prostate Cancer Cells by Inducing G1 Cell Cycle Arrest

  2019cites this paper
• The induction of Maspin expression by a glucosamine-derivative has an antiproliferative activity in prostate cancer cell lines.

  2019cites this paper
• Impact of Human Adipose Tissue-Derived Stem Cells on Malignant Melanoma Cells in An In Vitro Co-culture Model

  2018cites this paper
• Golgi Renaissance: the pivotal role of the largest Golgi protein giantin

  2018cites this paper
• The Tumorgenicity of Glioblastoma Cell Line U87MG Decreased During Serial In Vitro Passage

  2018cites this paper
• Inositol Polyphosphate 4-phosphatase Type II Regulation of Androgen Receptor Activity

  2018cites this paper
• Evaluation of phenotypic and functional stability of RAW 264.7 cell line through serial passages

  2018cites this paper
• Engineering cell heterogeneity into organs-on-a-chip.

  2018cites this paper
• The Role of Androgen Receptor in Prostate Cancer

  2018cites this paper
• Therapeutic Targeting of Sunitinib-Induced AR Phosphorylation in Renal Cell Carcinoma.

  2018cites this paper
• Genetic and transcriptional evolution alters cancer cell line drug response

  2018cites this paper
• Androgen receptor transcriptional activity and chromatin modifications on the ABCB1/MDR gene are critical for taxol resistance in ovarian cancer cells

  2018cites this paper
• Debugging Nano-Bio Interfaces: Systematic Strategies to Accelerate Clinical Translation of Nanotechnologies.

  2018cites this paper
• Non-Genomic Actions of the Androgen Receptor in Prostate Cancer

  2017cites this paper
• Artemisinin disrupts androgen responsiveness of human prostate cancer cells by stimulating the 26S proteasome-mediated degradation of the androgen receptor protein

  2017cites this paper
• Investigating the reproducibility of in vitro cell biology assays using mathematical models

  2017cites this paper
• Anti-androgen 2-hydroxyflutamide modulates cadherin, catenin and androgen receptor phosphorylation in androgen-sensitive LNCaP and androgen-independent PC3 prostate cancer cell lines acting via PI3K/Akt and MAPK/ERK1/2 pathways.

  2017cites this paper
• An investigation of epigenetic effects in Atherosclerosis

  2017cites this paper
• Androgen receptor and miR-206 regulation in prostate cancer

  2017cites this paper
• A computational modelling framework to quantify the effects of passaging cell lines

  2017influential citation
• SIDEseq: A Cell Similarity Measure Defined by Shared Identified Differentially Expressed Genes for Single-Cell RNA sequencing Data

  2017cites this paper
• Molecular mechanisms underlying resistance to androgen deprivation therapy in prostate cancer

  2016influential citation
• Modeling and Analysis of Hormone and Mitogenic Signal Integration in Prostate Cancer

  2016influential citation
• EZH2 induces methylation of ERG enhancing its transcriptional and transforming activity

  2016cites this paper
• ErbB2 Signaling Increases Androgen Receptor Expression in Abiraterone-Resistant Prostate Cancer

  2016cites this paper
• Combined MYC Activation and Pten Loss Are Sufficient to Create Genomic Instability and Lethal Metastatic Prostate Cancer.

  2016cites this paper
• AR-V7 and prostate cancer: The watershed for treatment selection?

  2016cites this paper
• Androgen receptor-mediated non-genomic effects of vinclozolin on porcine ovarian follicles and isolated granulosa cells: Vinclozolin and non-genomic effects in porcine ovarian follicles.

  2016cites this paper
• RAS and sex differences in diabetic nephropathy.

  2016cites this paper
• The safety and efficacy of enzalutamide in the treatment of advanced prostate cancer

  2016cites this paper
• Integrative transcriptomics-based identification of cryptic drivers of taxol-resistance genes in ovarian carcinoma cells: Analysis of the androgen receptor

  2015cites this paper
• Survey of phosphorylation near drug binding sites in the Protein Data Bank (PDB) and their effects

  2015cites this paper
• Inhibition of Pten deficient Castration Resistant Prostate Cancer by Targeting of the SET - PP2A Signaling axis

  2015cites this paper
• Human kallikrein 2 (KLK2) promotes prostate cancer cell growth via function as a modulator to promote the ARA70-enhanced androgen receptor transactivation

  2014cites this paper
• Emerging roles of radioresistance in prostate cancer metastasis and radiation therapy

  2014cites this paper
• Transcriptomic profiling of taxol-resistant ovarian cancer cells identifies FKBP5 and the androgen receptor as critical markers of chemotherapeutic response

  2014cites this paper
• Androgen receptor signaling in prostate cancer

  2014cites this paper
• Rapid Induction of Androgen Receptor Splice Variants by Androgen Deprivation in Prostate Cancer

  2014cites this paper
• Cellular prostatic acid phosphatase, a PTEN-functional homologue in prostate epithelia, functions as a prostate-specific tumor suppressor.

  2014cites this paper
• PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors

  2014cites this paper
• SURFACE PLASMON RESONANCE IN LIVING CELL SENSING − SPR Responses in Cell-Exosome Interactions

  2014cites this paper
• Chapter-10 Prostate Cancer

  2014cites this paper
• The role of TXNDC5 in castration-resistant prostate cancer—involvement of androgen receptor signaling pathway

  2014cites this paper
• Prostate cancer: the significance of the cAMP signalling pathway

  2014cites this paper
• Androgen receptor functions in castration-resistant prostate cancer and mechanisms of resistance to new agents targeting the androgen axis

  2014cites this paper
• Androgen receptor phosphorylation: biological context and functional consequences.

  2014cites this paper
• PGE2 modulates the transcriptional activity of ERRa in prostate stromal cells

  2014cites this paper
• Abreviated title: Androgen Receptor phosphorylation.

  2014cites this paper
• Influence of trypsinization and alternative procedures for cell preparation before RNA extraction on RNA integrity.

  2014cites this paper
• Androgen Receptor Phosphorylation at Serine 308 and Serine 791 Predicts Enhanced Survival in Castrate Resistant Prostate Cancer Patients

  2013cites this paper
• Posttranslational Modification of the Androgen Receptor in Prostate Cancer

  2013cites this paper
• Roles of Androgen Receptor Coregulators and Cell Signaling in the Regulation of Androgen-Responsive Genes

  2013cites this paper
• Identification and classification of prostate tumour tissues by FTIR

  2013cites this paper
• Altered cholesterol metabolism in human cancers unraveled by label-free spectroscopic imaging

  2013cites this paper
• Androgen Receptor-Regulated Genes in Prostate Cancer Initiation Versus Metastasis

  2013cites this paper
• Estrogen receptor β expression and androgen receptor phosphorylation correlate with a poor clinical outcome in hormone-naive prostate cancer and are elevated in castration-resistant disease.

  2013cites this paper
• Androgen receptors in early and castration resistant prostate cancer: friend or foe?

  2013cites this paper
• Clinical significance of androgen receptor and its phosphorylated form in breast cancer.

  2013cites this paper
• Mini-review: androgen receptor phosphorylation in prostate cancer.

  2013cites this paper
• Phosphorylation: a fundamental regulator of steroid receptor action.

  2013cites this paper
• Cancer Metastasis Promotion versus Suppression of Prostate Anti-androgen Receptor ASC-J9® Lead to MDV3100/Enzalutamide versus Casodex/Bicalutamide or Therapies with Anti-androgens Differential Androgen Deprivation Molecular Bases of Disease:

  2013cites this paper
• Differential Androgen Deprivation Therapies with Anti-androgens Casodex/Bicalutamide or MDV3100/Enzalutamide versus Anti-androgen Receptor ASC-J9® Lead to Promotion versus Suppression of Prostate Cancer Metastasis*

  2013cites this paper
• Androgen-Responsive Genes in Prostate Cancer

  2013cites this paper
• The role of intracrine androgen metabolism, androgen receptor and apoptosis in the survival and recurrence of prostate cancer during androgen deprivation therapy.

  2013cites this paper
• Experimental Evidence of Persistent Androgen-Receptor-Dependency in Castration-Resistant Prostate Cancer

  2013cites this paper
• New therapeutic approach to suppress castration-resistant prostate cancer using ASC-J9 via targeting androgen receptor in selective prostate cells.

  2013cites this paper
• Androgeenireseptorin tumatranslokaatio, FOXA1-vuorovaikutus ja liikkuvuus ihmisen soluissa

  2012cites this paper
• Low androgen sensitivity is associated with low levels of Akt phosphorylation in LNCaP-E9 cells.

  2012cites this paper
• PAGE4 positivity is associated with attenuated AR signaling and predicts patient survival in hormone-naive prostate cancer.

  2012cites this paper
• Differential Functions of Stromal and Epithelial Androgen Receptor in Prostate Cancer Before and After Castration Resistant Stage

  2012cites this paper
• Exposure to Dietary Selenium and Soy Isoflavones in Utero Provides Greater Protection Against Prostate Cancer Risk Factors in TRAMP Mice than Exposure Beginning at 6 Weeks

  2012cites this paper
• Solid Tumour Target Discovery Group, Newcastle Cancer Centre at the Northern Institute for Cancer

  2012cites this paper
• Advances in Rapid Sex-Steroid Action

  2012cites this paper
• PTEN genomic deletion predicts prostate cancer recurrence and is associated with low AR expression and transcriptional activity

  2012cites this paper
• Antiandrogenic activity of resveratrol analogs in prostate cancer LNCaP cells.

  2012cites this paper